Document is current

Any future updates will be listed below

4 Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumour responses and modulates the tumour immune microenvironment

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.0004

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark